0001062993-24-014086.txt : 20240725 0001062993-24-014086.hdr.sgml : 20240725 20240725163103 ACCESSION NUMBER: 0001062993-24-014086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240723 FILED AS OF DATE: 20240725 DATE AS OF CHANGE: 20240725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hippel James CENTRAL INDEX KEY: 0001603594 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 241142484 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-07-23 0000842023 BIO-TECHNE Corp TECH 0001603594 Hippel James 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 1 0 0 CFO 0 Common Stock 2024-07-23 4 M 0 35000 31.26 A 107284 D Common Stock 2024-07-23 4 F 0 24282 77.77 D 83002 D Stock Options (Right to Buy) 31.26 2024-07-23 4 M 0 35000 0 D 2024-08-09 Common Stock 35000 106867 D Stock Options (Right to Buy) 44.33 2025-08-08 Common Stock 168620 168620 D Stock Options (Right to Buy) 47.60 2026-08-07 Common Stock 186068 186068 D Stock Options (Right to Buy) 66.97 2027-08-05 Common Stock 90740 90740 D Stock Options (Right to Buy) 66.97 2027-08-05 Common Stock 76588 76588 D Restricted Stock Units Common Stock 7780 7780 D Performance Stock Options (Right to Buy) 120.46 2028-08-06 Common Stock 30400 30400 D Stock Options (Right to Buy) 120.46 2028-08-06 Common Stock 40536 40536 D Restricted Stock Units Common Stock 10912 10912 D Performance Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 33916 33916 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 45220 45220 D Restricted Stock Units Common Stock 13865 13865 D Performance Stock Options (Right to Buy) 84.61 2030-08-15 Common Stock 37314 37314 D Stock Options (Right to Buy) 84.61 2030-08-15 Common Stock 45923 45923 D Restricted Stock Units Common Stock 26318 26318 D The Reporting Person's direct ownership has been increased by 400 shares pursuant to a clerical error in a previous filing. Fully exercisable. Options to purchase 19,147 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025. Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. 13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025. /s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed 2024-07-25